In the latest quarter, 11 analysts provided ratings for Klaviyo (NYSE:KVYO), showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings, shedding light ...
Lexicon Pharmaceuticals (NASDAQ:LXRX) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results